Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 6/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | CCR1 | P32246 | 2/20 | 0.47 |
| ▸ | CCR5 | P51681 | 2/20 | 0.47 |
| ▸ | CCR8 | P51685 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | ALPI | P09923 | 1/20 | 0.47 |
| ▸ | ALPG | P10696 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 5/20 | 0.46 |
| ▸ | METAP1 | P53582 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13726458 | 0.98 | TGFBR1 (0.49) | TGFBR1KDM4ESMN1; SMN2LMNATP53 | |
| SCHEMBL13727834 | 0.95 | KDM4E (0.47) | TGFBR1KDM4ESMN1; SMN2LMNATP53 | |
| SCHEMBL13727080 | 0.93 | KDM4E (0.49) | TGFBR1KDM4ESMN1; SMN2LMNATP53 | |
| SCHEMBL13727515 | 0.92 | L3MBTL1 (0.50) | TGFBR1KDM4ESMN1; SMN2LMNATP53 | |
| SCHEMBL13726500 | 0.91 | L3MBTL1 (0.49) | TGFBR1KDM4ESMN1; SMN2LMNATP53 | |
| SCHEMBL13726490 | 0.91 | L3MBTL1 (0.51) | TGFBR1KDM4ESMN1; SMN2LMNATP53 | |
| SCHEMBL13820014 | 0.87 | L3MBTL1 (0.47) | TGFBR1KDM4ELMNAMAPK1HTT | |
| SCHEMBL13728155 | 0.85 | NPC1 (0.52) | TGFBR1KDM4ESMN1; SMN2LMNATP53 | |
| SCHEMBL13726246 | 0.85 | L3MBTL1 (0.49) | TGFBR1KDM4ELMNAMAPK1HTT | |
| SCHEMBL13728222 | 0.85 | DHODH (0.49) | TGFBR1KDM4ESMN1; SMN2LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586740-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-11-19 | — | — | US | disclosed |
| US-20130049577-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2013-02-28 | — | — | US | disclosed |
| US-20130049577-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2013-02-28 | — | — | US | disclosed |
| US-20090203704-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-08-13 | — | — | US | disclosed |
| US-20090203704-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-08-13 | — | — | US | disclosed |
| EP-2065378-A1 | Quinoxaline derivate, and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative | Semiconductor Energy Laboratory Co, Ltd. (JP) | 2009-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203704-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | PDXK, NQO1, PPOX | TGFBR1 4240/4885KDM4E 1083/4885SMN1; SMN2 4090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.